STAT3 mutations were detected by NGS in peripheral blood, bone marrow, and spleen in a total of 56% of patients in our cohort, providing an argument for considering these cases as atypical aleukemic presentation of T-LGL leukemia. Here, STAT3 is linked to T-cell large granular lymphocyte leukemia.